Publication of eQUEST Study Results Demonstrate that eSight 3 is a Clinically Effective Device for the Visually Impaired
Significant results to be published in September 2018 issue of Optometry and Vision Science. Read more >>
05Sep
Related Posts
01Mar
AR for the Blind
If you watched Star Trek in the 1980s and 1990s, you probably remember Geordi La Forge. He was blind but... read more
14Dec
For their holidays, a gift of improved vision
Ballet Austin put on a private showing of the classic ballet for a group of visually impaired Austin-area people who... read more
18Feb
Elizabeth Banks’ Instagram snake giveaway is a game changer for celebrity wine marketing
The canned-wine company Archer Roose, its latest promotion: the Archer Roose Snake Rewards Program. Actor Elizabeth Banks — an investor... read more
27May
S’more product lead & Ad Club honoree Regina Guinto on the influencer-fueled future
Every year, the Advertising Club of New York, often abbreviated as Ad Club, honors some of the top talent in... read more
16May
Corbus Pharmaceuticals Announces Acceptance of Three Abstracts for Presentation at EULAR 2018 Annual Meeting
Corbus Pharmaceuticals Holdings, Inc., a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to... read more
30May
Marlborough Woman Gets eSight Glasses With Community’s Help
A Marlborough, Massachusetts, woman is using new eSight glasses to read menus and distinguish facial expressions from a distance after... read more
27Sep
Bible Hill woman hopes to raise funds for a device that can enhance her vision
Most of us take such things for granted – reading print at a comfortable distance, identifying which car is yours... read more
16Dec
Lincoln Financial Group Announces Launch of Financial Wellness Marketplace for Employer Customers
Lincoln Financial Group’s Workplace Solutions business announced today an expansion of its financial wellness program with the launch of a... read more
15Aug
Myomo, Inc. Reports Second Quarter 2017 Results
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today reports its financial results... read more
07Nov
Dr. Adam Friedman to Present Keynote at Dermatology Fall Update
Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, announced that its scientific advisor, Adam Friedman MD, will... read more